1. Consiglio Nazionale Delle Ricerche (4 from 312 patents)

2. Nektar Therapeutics (3 from 415 patents)

3. Applied Research Systems Ars Holding N.v. (3 from 156 patents)

4. Serina Therapeutics, Inc. (3 from 23 patents)

5. Nektar Therapeutics Al, Corporation (1 from 45 patents)

6. Debiopharm S.a. (1 from 28 patents)

7. Shearwater Polymers, Inc. (1 from 6 patents)

8. Debio Recherche Pharmaceutique (1 from 1 patent)

1. 10864276 - Activated polyoxazolines and conjugates and compositions comprising the same

2. 10086084 - Activated polyoxazolines and conjugates and compositions comprising the same

3. 8546493 - Multi-armed, monofunctional, and hydrolytically stable derivatives of poly(ethylene glycol) and related polymers for modification of surfaces and molecules

4. 8354477 - Multi-armed, monofunctional, and hydrolytically stable derivatives of poly(ethylene glycol) and related polymers for modification of surfaces and molecules

5. 7943141 - Activated polyoxazolines and compositions comprising the same

6. 7786221 - Multi-armed, monofunctional, and hydrolytically stable derivatives of poly (ethylene glycol) and related polymers for modification of surfaces and molecules

7. 7419600 - Method for purifying a branched water-soluble polymer

8. 7317002 - Site-specific preparation of polyethylene glycol-GRF conjugates

9. 6869932 - Site-specific preparation of polyethlene glycol-GRF conjugates

10. 6790942 - Biologically active conjugates having a detectable reporter moiety and method of identification of the derivative

11. 6528485 - Site-specific preparation of polyethylene glycol-grf conjugates

12. 5932462 - Multiarmed, monofunctional, polymer for coupling to molecules and

13. 5631336 - Chain-terminated N-vinyl lactam polymers and graft-copolymers and

14. 5631322 - Polymers of N-acryloylmorpholine activated at one end and conjugates

15. 5629384 - Polymers of N-acryloylmorpholine activated at one end and conjugates